Xtampza ER oxycodone extended-release regulatory update

Last month, Collegium submitted an NDA to FDA for oral Xtampza ER oxycodone extended-release to treat chronic pain. The abuse-deterrent analgesic uses the company’s DETERx tamper resistance technology...